OLFML2A mediates cell cycle regulation in triple-negative breast cancer via EZH2
Our findings suggest that OLFML2A may facilitate cell cycle progression by regulating EZH2, implicating it as a potential therapeutic target for triple-negative breast cancer.
Authors
- Y. Ann Chen (ORCID: https://orcid.org/0000-0003-1468-3490)
- Qinghong Yu (ORCID: https://orcid.org/0000-0002-7326-7609)
- Hanyue Ding (ORCID: https://orcid.org/0000-0001-9977-0985)
- Wanzhi Jiang
- Xiufei Gao (ORCID: https://orcid.org/0000-0002-3188-2216)
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fonc.2025.1750297
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00